The role of ubiquitin-specific peptidases in glioma progression

Biomed Pharmacother. 2022 Feb:146:112585. doi: 10.1016/j.biopha.2021.112585. Epub 2021 Dec 27.

Abstract

The balance between ubiquitination and deubiquitination is crucial for protein stability, function and location under physiological conditions. Dysregulation of E1/E2/E3 ligases or deubiquitinases (DUBs) results in malfunction of the ubiquitin system and is involved in many diseases. Increasing reports have indicated that ubiquitin-specific peptidases (USPs) play a part in the progression of many kinds of cancers and could be good targets for anticancer treatment. Glioma is the most common malignant tumor in the central nervous system. Clinical treatment for high-grade glioma is unsatisfactory thus far. Multiple USPs are dysregulated in glioma and have the potential to be therapeutic targets. In this review, we collected studies on the roles of USPs in glioma progression and summarized the mechanisms of USPs in glioma tumorigenesis, malignancy and chemoradiotherapy resistance.

Keywords: Deubiquitinases; Glioma; Ubiquitin-specific peptidases.

Publication types

  • Review

MeSH terms

  • Animals
  • Autophagy / physiology
  • Carcinogenesis / metabolism
  • DNA Repair / physiology
  • Drug Resistance, Neoplasm / physiology
  • Glioma / physiopathology*
  • Humans
  • Radiation Tolerance / physiology
  • Signal Transduction / physiology
  • Ubiquitin-Protein Ligases / physiology*
  • Ubiquitin-Specific Proteases / metabolism*
  • Ubiquitination / physiology*

Substances

  • Ubiquitin-Protein Ligases
  • Ubiquitin-Specific Proteases